We are live on ! Find out more
FMWA

Forvis Mazars Wealth Advisors Portfolio holdings

AUM $5.27B
1-Year Est. Return 18.06%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+18.06%
3 Year Est. Return
+51.15%
5 Year Est. Return
+52.01%
10 Year Est. Return
+190.2%
AUM
$2.38B
AUM Growth
+$201M
Cap. Flow
+$50.3M
Cap. Flow %
2.12%
Top 10 Hldgs %
66.16%
Holding
288
New
17
Increased
124
Reduced
109
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 5.15%
2 Healthcare 2.66%
3 Financials 2.21%
4 Consumer Discretionary 1.9%
5 Consumer Staples 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
101
American Express
AXP
$228B
$2M 0.08%
12,221
-1,000
-8% -$171K
CVS icon
102
CVS Health
CVS
$134B
$2M 0.08%
19,352
+730
+4% +$67.5K
UNP icon
103
Union Pacific
UNP
$172B
$1.94M 0.08%
7,710
+109
+1% +$25.8K
TRV icon
104
Travelers Companies
TRV
$78.4B
$1.94M 0.08%
12,392
+609
+5% +$95.2K
VLO icon
105
Valero Energy
VLO
$92.6B
$1.88M 0.08%
24,970
+657
+3% +$48.9K
DRI icon
106
Darden Restaurants
DRI
$23.7B
$1.85M 0.08%
12,260
+749
+7% +$111K
IBDR icon
107
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.44B
0
ROP icon
108
Roper Technologies
ROP
$38.5B
$1.81M 0.08%
3,682
+71
+2% +$33.8K
RTX icon
109
RTX Corp
RTX
$289B
$1.81M 0.08%
21,048
-148
-0.7% -$12.9K
XLB icon
110
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$1.81M 0.08%
39,958
-104
-0.3% -$4.49K
JMST icon
111
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.12B
$1.76M 0.07%
34,434
+16,811
+95% +$858K
REGN icon
112
Regeneron Pharmaceuticals
REGN
$77.4B
$1.74M 0.07%
2,760
+438
+19% +$269K
PRFZ icon
113
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
$1.72M 0.07%
44,890
-70
-0.2% -$2.67K
CL icon
114
Colgate-Palmolive
CL
$73.3B
$1.72M 0.07%
20,128
-1,531
-7% -$120K
KO icon
115
Coca-Cola
KO
$381B
$1.72M 0.07%
28,992
+2,041
+8% +$114K
DHR icon
116
Danaher
DHR
$138B
$1.71M 0.07%
5,876
+106
+2% +$29.2K
XLC icon
117
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$1.66M 0.07%
21,374
-688
-3% -$54.4K
OEF icon
118
iShares S&P 100 ETF
OEF
$19.9B
$1.66M 0.07%
7,560
-101
-1% -$21.4K
PEG icon
119
Public Service Enterprise Group
PEG
$38.6B
$1.63M 0.07%
24,388
+1,191
+5% +$75.4K
SPYG icon
120
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51B
$1.57M 0.07%
21,721
-602
-3% -$42K
IBDP
121
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
0
AMP icon
122
Ameriprise Financial
AMP
$48.1B
$1.43M 0.06%
4,747
-37
-0.8% -$10.9K
ECL icon
123
Ecolab
ECL
$78.6B
$1.38M 0.06%
5,882
+285
+5% +$64.4K
STZ icon
124
Constellation Brands
STZ
$22.3B
$1.37M 0.06%
5,471
+416
+8% +$94.8K
NEE icon
125
NextEra Energy
NEE
$183B
$1.31M 0.06%
14,084
+121
+0.9% +$10.5K

Similar funds

Forvis Mazars Wealth Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Forvis Mazars Wealth Advisors held 288 positions worth $2.38B, up 9.2% from $2.18B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Forvis Mazars Wealth Advisors's Q4 2021 filing shows 17 new, 124 increased, 109 reduced and 3 closed positions. Its largest new stake was MetLife: 10,141 shares worth $634K. The largest sale was Eli Lilly, an estimated $881K.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Financials.

  • Forvis Mazars Wealth Advisors's largest Q4 2021 buy was MetLife: 10,141 shares worth $634K.
  • Forvis Mazars Wealth Advisors added most to Vanguard FTSE All-World ex-US ETF in Q4 2021, an estimated $14.9M increase.
  • Forvis Mazars Wealth Advisors's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $881K.
  • Forvis Mazars Wealth Advisors fully exited NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND in Q4 2021, selling an estimated $531K.
  • Forvis Mazars Wealth Advisors's ten largest holdings make up 66% of its $2.38B portfolio in Q4 2021.
  • Forvis Mazars Wealth Advisors opened 17 new positions and closed 3 in Q4 2021.
  • Forvis Mazars Wealth Advisors's portfolio value rose 9.2% quarter-over-quarter to $2.38B.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q4 2021, filed 14 Jan 2022.